Role of transthoracic echocardiogram in acute heart failure

Acute Heart Failure (AHF) is an increasingly common condition with a poor prognosis. In contrast to CHF where advances in medical therapy and devices has led to significant improvement in morbidity and mortality, the prognosis for AHF has not changed significantly in the last few decades despite...

Full description

Bibliographic Details
Main Authors: Sarah Fitzsimons, Robert N Doughty
Format: Article
Language:English
Published: IMR (Innovative Medical Research) Press Limited 2021-09-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://rcm.imrpress.com/fileup/2153-8174/PDF/1632453069897-550952620.pdf
id doaj-555c02d82f44415a8c3ca79d4e54b15a
record_format Article
spelling doaj-555c02d82f44415a8c3ca79d4e54b15a2021-09-26T07:42:32ZengIMR (Innovative Medical Research) Press LimitedReviews in Cardiovascular Medicine2153-81742021-09-0122374175410.31083/j.rcm22030811632453069897-550952620Role of transthoracic echocardiogram in acute heart failureSarah Fitzsimons0Robert N Doughty1Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 1023 Auckland, New ZealandDepartment of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 1023 Auckland, New ZealandAcute Heart Failure (AHF) is an increasingly common condition with a poor prognosis. In contrast to CHF where advances in medical therapy and devices has led to significant improvement in morbidity and mortality, the prognosis for AHF has not changed significantly in the last few decades despite efforts to find effective treatment. There are multiple factors that contribute to the high mortality and morbidity of AHF; it can be a diagnostic challenge, determining whether decongestion has been achieved can be difficult, and persisting congestion is commonly present at discharge contributing to early decompensation and rehospitalisation. Transthoracic echocardiogram (TTE) is a unique imaging modality that is non-invasive, can be done at the bedside, in real time during procedures, is affordable and easy to access both in community and inpatient settings. Small hand held ‘point of care’ scans are increasingly available and being used as an adjunct to improve clinical examination. Consequently, the use of echocardiography to improve outcomes for patients with cardiac disease continues to evolve. In chronic heart failure TTE has established roles in the quantification of HF phenotype, and determination of treatment initiation, escalation and success. However, the role of echocardiogram in AHF is not as well established with society guidelines relying on expert consensus for their recommendations. Use of TTE at all stages of AHF has potential to reduce morbidity and mortality. This review discusses the evidence for use of TTE to improve the diagnosis, prognosis and management of AHF.https://rcm.imrpress.com/fileup/2153-8174/PDF/1632453069897-550952620.pdfacute heart failuretransthoracic echocardiogramdiagnosisprognosistreatment
collection DOAJ
language English
format Article
sources DOAJ
author Sarah Fitzsimons
Robert N Doughty
spellingShingle Sarah Fitzsimons
Robert N Doughty
Role of transthoracic echocardiogram in acute heart failure
Reviews in Cardiovascular Medicine
acute heart failure
transthoracic echocardiogram
diagnosis
prognosis
treatment
author_facet Sarah Fitzsimons
Robert N Doughty
author_sort Sarah Fitzsimons
title Role of transthoracic echocardiogram in acute heart failure
title_short Role of transthoracic echocardiogram in acute heart failure
title_full Role of transthoracic echocardiogram in acute heart failure
title_fullStr Role of transthoracic echocardiogram in acute heart failure
title_full_unstemmed Role of transthoracic echocardiogram in acute heart failure
title_sort role of transthoracic echocardiogram in acute heart failure
publisher IMR (Innovative Medical Research) Press Limited
series Reviews in Cardiovascular Medicine
issn 2153-8174
publishDate 2021-09-01
description Acute Heart Failure (AHF) is an increasingly common condition with a poor prognosis. In contrast to CHF where advances in medical therapy and devices has led to significant improvement in morbidity and mortality, the prognosis for AHF has not changed significantly in the last few decades despite efforts to find effective treatment. There are multiple factors that contribute to the high mortality and morbidity of AHF; it can be a diagnostic challenge, determining whether decongestion has been achieved can be difficult, and persisting congestion is commonly present at discharge contributing to early decompensation and rehospitalisation. Transthoracic echocardiogram (TTE) is a unique imaging modality that is non-invasive, can be done at the bedside, in real time during procedures, is affordable and easy to access both in community and inpatient settings. Small hand held ‘point of care’ scans are increasingly available and being used as an adjunct to improve clinical examination. Consequently, the use of echocardiography to improve outcomes for patients with cardiac disease continues to evolve. In chronic heart failure TTE has established roles in the quantification of HF phenotype, and determination of treatment initiation, escalation and success. However, the role of echocardiogram in AHF is not as well established with society guidelines relying on expert consensus for their recommendations. Use of TTE at all stages of AHF has potential to reduce morbidity and mortality. This review discusses the evidence for use of TTE to improve the diagnosis, prognosis and management of AHF.
topic acute heart failure
transthoracic echocardiogram
diagnosis
prognosis
treatment
url https://rcm.imrpress.com/fileup/2153-8174/PDF/1632453069897-550952620.pdf
work_keys_str_mv AT sarahfitzsimons roleoftransthoracicechocardiograminacuteheartfailure
AT robertndoughty roleoftransthoracicechocardiograminacuteheartfailure
_version_ 1716868382261772288